The most important way to prevent atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.
Guideline
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Expert Consensus Documents
- 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment
- 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Certified Education
- Guideline Education: Non-Pharmacologic Management of Hypertension
- Role of Ezetimibe in Secondary Prevention of CAD
- Guideline Education: Treating Hypertension in the African American Patient
- Guideline Education: Diagnosis and Management of Hypertension
- Guideline Education: Managing the Complex Hypertensive Patient With Chronic Kidney Disease
- Guideline Education: Making the Case for Intensification of Statins
- Guideline Education: Presence of Subclinical Atherosclerosis on CAC Scoring